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ABSTRACT
The aim of this study was to evaluate the effect of diclofenac on the disposition and renal clearance of 
amoxicillin. In this cross over study with a 1 week washout period, 10 ewes received amoxicillin intravenously 
(10 mg/kg body mass) alone or plus diclofenac sodium (2.5 mg/kg b.m.), given intramuscularly 30 minutes 
prior to amoxicillin administration. Concentrations of amoxicillin in plasma and urine were measured using 
high performance liquid chromatography (HPLC) with ﬂ  uorescence detection. Concomitant administration of 
diclofenac with amoxicillin resulted in no signiﬁ  cant alterations in the pharmacokinetic parameters or renal 
elimination for amoxicillin following intravenous administration. Intravenous administration of amoxicillin 
alone or concomitant with diclofenac resulted in mean ± SD elimination half-life (t1/2), of 0.79 ± 0.11 h versus 
0.8 ± 0.09 h, mean residence time (MRT) of 0.8 ± 0.15 h versus 0.9 ± 0.17 h, total body clearance (CLB) 
of 0.25 ± 0.02 L/h/kg vs 0.24 ± 0.04 L/h/kg and area under the curves (AUC) of 35.2 ± 6.2 g/h/mL vs 
39.5 ± 5.7 g/h/mL, respectively. Amoxicillin was eliminated unchanged via the urine, with renal clearance 
(ClR) of 0.24 ± 0.05 L/h/kg and 0.27 ± 0.07 L/h/kg in the animal given amoxicillin alone or concomitant with 
diclofenac, respectively. Concurrent administration of diclofenac had no signiﬁ  cant effect on the single-dose 
pharmacokinetics or renal elimination of amoxicillin given intravenously in ewes.
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Introduction
Amoxicillin (AMX), a broad spectrum a-amino-p hydroxybenzylpenicillin, is a 
commonly used antibiotic in veterinary medicine, which has improved bioavailability 
after oral administration (SUTHERLAND et al., 1972; VERBIST, 1974). AMX is used 
successfully alone or in combination with clavulanic acid for the treatment of severe 
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respiratory, gastrointestinal, urinary, dermal and dental infections (PALMER et al., 1976; 
PRESCOT, 2000).
Diclofenac is a nonsteroidal anti-inﬂ  ammatory drug (NSAID) with excellent analgesic 
and anti-pyretic activities. It acts via inhibition of cyclooxygenase (COX), which catalyzes 
the rate-limiting step in the formation of prostanoids, prostaglandins and thromboxane 
A2 (FITZGERALD and PATRONO, 2001). Antibiotic and non-steroidal anti-inﬂ  ammatory 
agents are frequently used concomitantly in human and animals by oral or injectable 
routes. Drug interactions were veriﬁ  ed when diclofenac was given concomitantly with 
amoxicillin orally. Diclofenac reduced the serum and tissue concentration of amoxicillin, 
as well as its antibacterial activity and increased its total body clearance by 18% according 
to other studies by GROPPO et al. (2004) and BERGAMASCHI et al. ( 2006). It has been 
postulated that the later effect of diclofenac on amoxicillin is due   to its effect on the 
absorption as well as the renal excretion of amoxicillin. However, these previous studies 
could not provide any information about the effect of diclofenac on the renal clearance 
of amoxicillin. The purpose of this study was to assess the effect of concomitantly 
administered diclofenac on the pharmacokinetics and urinary excretion of amoxicillin 
given intravenously in ewes.
Materials and methods
Drugs. A commercially available amoxicillin preparation (E-Mox, 1 g sterile powder, 
Eippico, Cairo, Egypt) was used as an aqueous solution of 200 mg/mL. Diclofenac sodium 
(Voltaren, Novartis Co., Switzerland) was purchased as a 2.5 mg/mL injectable solution.
Animals. Ten ewes, ranging in age from 1-1.5 years and weighing 42.4-55.6 kg, 
were used. All ewes were considered healthy by clinical examination, complete blood 
picture, biochemical blood analysis and urinalysis. Each ewe was housed in a separate 
well-ventilated hygienic pen. Feed consisted of alfalfa hay, concentrate and green fodder, 
and drinking water was provided ad libitum. 
Experimental design. A two-period cross-over design study, with a 1 week washout 
period, was conducted. Each animal received amoxicillin sodium by intravenous route 
(10 mg/kg body mass) alone or plus diclofenac sodium (2.5 mg/kg body mass) given 
intramuscularly 30 minutes prior to the amoxicillin. Blood samples were collected 
from the left jugular vein into heparinized syringes before and 5, 10, 15, 30 minutes 
and 1, 2, 4, 6, 8, 10, 12, 24 and 48 hrs after amoxicillin injection. Plasma was separated 
by centrifugation at 2000 g for 10 min and stored at -20 oC until assayed. The ewes 
were catheterized with an indwelling balloon catheter (Foley urinary catheter, No. 12, 
Timedco, Atlanta, Ga.). Catheters were connected to a 2 L container. Urine samples were 
collected just before and at 30 minutes and 1, 2, 4, 6, 8, 10, 12, 24, 36 and 48 hours 33 Vet. arhiv 84 (1), 31-39, 2014
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after administration of the drug. The volume of urine voided at each sampling time was 
measured and 10 mL aliquots were kept at -70 C until assayed.
Amoxicillin assay 
Instrumentation. Drug concentration in plasma was determined using reverse phase 
high performance liquid chromatography (HPLC), according to the method previously 
explained by DELIS et al. (2009a). The HPLC system consisted of an autosampler, equipped 
with a temperature - controlled rack (Waters), controller, solvent delivery pump (Waters, 
Milford, MA, USA), , and variable wave length ﬂ  uorescence detector.
Chromatographic conditions. The mobile phase (35:65, v/v) of acetonitrile and 
a phosphate buffer (potassium dihydrogen phosphate 50 mM) containing 5 mM 
1-octanesulfonic acid sodium salt monohydrate. pH of the mobile was adjusted to 3.5 
with 1 M ortho-phosphoric acid. Separation was accomplished using a reverse phase C18 
column (Discovery, Supelco, 5 μm, 4.6×150 mm). The emission wavelengths were 355 
and 435 nm, and the ﬂ  ow rate was 1 mL/min.
Calibration curve. For preparation of the calibration curve, antibiotic naïve ewes 
plasma and urine were spiked with 0.01, 0.05, 0.1, 0.5, 1.0 and 5.0 g/mL amoxicillin, 
and ampicillin was used as the internal standard. The standard curves of amoxicillin in the 
plasma and urine were linear between 0.01 and 5 μg/mL. The correlation coefﬁ  cients (r) 
of standard curves were >0.97 for plasma and urine with lower quantitation limit (LOQ) 
of 0.01 g/mL.
Sample extraction. The plasma and urine samples or calibration standards to be 
assayed (300 μL) were placed in centrifuge tube and spiked with 75 μL of internal 
standard (ampicillin 5 μg/mL in 0.05 M phosphate buffer) and vortexed. Plasma and 
urine samples (1 mL) were extracted by addition of 150 μL perchloric acid (20%) and 
samples were then vortexed, the supernatant was taken by aspiration and 150 μL aliquot 
were transferred to autosampler and the injection volume was adjusted to 20 μL. 
Validation of the assay method. The precision and accuracy of the method were 
evaluated by repetitive analysis of the plasma and urine samples (n = 10) spiked with 
0.01, 0.5, 1 and 5 μg/mL amoxicillin. The recovery was calculated by comparison of the 
extracted plasma and urine samples with those of the similar standard concentrations in 
the mobile phase (n = 10).
The values of intra-assay and interassay precision were <3.7% for plasma and urine 
samples. The intra-assay and interassay accuracies were >94% for plasma and urine. 
Recovery of amoxicillin from plasma and urine was >89%.
Pharmacokinetics analysis. The plasma concentration versus time data of the drug 
were ﬁ  tted to a two compartment open model system (BAGGOT, 1978) according to the 
following biexponential equation: Ct = Ae-αt + Be-βt where Ct is the plasma concentration 34 Vet. arhiv 84 (1), 31-39, 2014
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of amoxicillin; t is time after intravenous administration; A and α are the intercept and 
slope, respectively in the distribution phase; B and β are the intercept and slope of the 
elimination phase. Pharmacokinetic variables were calculated by the WinNonlin program 
(Pharsight Corporation, Mountain View, CA, USA). The distribution and elimination 
half-lives (t1/2α and t1/2β), the volume of distribution at steady state (Vdss) and the total 
body clearance (ClB) were calculated according to standard equations (GIBALDI and 
PERRIER, 1982). The area under the plasma concentration time curve (AUC0-∞) and the 
area under the ﬁ  rst moment curve (AUMC0-∞) were calculated by the trapezoidal rule for 
all measured data, with extrapolation to inﬁ  nity using Clast/β, where Clast is the plasma 
concentration at 8 hours in ewes treated with amoxicillin alone or plus diclofenac. The 
mean residence time (MRT) was calculated as MRT = AUMC0-∞/AUC0-∞. 
The renal clearance (CLR) of amoxicillin was determined using plasma and urine 
concentrations of the drug and urine volume for samples collected over the sampling 
interval from 0 to 12 h. post i.v. administration of the drug. The following equation was 
used for calculation (ISMAIL, 2005):
In this equation, (A × V)0-12 is the cumulative amount of the drug excreted during 
the sampling period from 0 to 12 h, where A is the concentration of amoxicillin excreted 
in each urine sample; V is the volume of urine sample; AUC0-∞ is the area under the 
concentration time curve over the same sampling period and b.m. is the mass of each ewe 
in kilograms.
 Estimation of endogenous creatinine clearance. The levels of creatinine in plasma 
and urine samples were estimated according to SIEST et al. (1985) using a commercial 
creatinine diagnostic kit (Bio Merieux, Paris, France). Endogenous creatinine clearance 
(CLcr) was calculated by standard clearance equation. Fractional clearance (CLR/CLcr) of 
the drug was calculated as the ratio between its renal clearance and endogenous creatinine 
clearance (OSBALDISTON, 1971). 
 Statistical analysis. All the data are presented as mean S.D. One-way analysis of 
variance (ANOVA) was performed by SPSS® 6.1.3 software package (SAS, Cary, NC, 
USA) and signiﬁ  cant differences between the means assessed using the student t test . 
Statistical signiﬁ  cance was set at P<0.05.
Results
Following intravenous administration of amoxicillin (10 mg/kg) alone or plus 
diclofenac in all ewes, the plasma concentration versus time data complied with the 35 Vet. arhiv 84 (1), 31-39, 2014
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two compartment open model and exhibited a biphasic decline. Table 1 shows the 
pharmacokinetic parameters of amoxicillin following i.v. administration alone or plus 
diclofenac in ewes. There was no signiﬁ  cant difference in any of the tested pharmacokinetic 
variables reported in this study.
Table 1. Pharmacokinetic variables (Mean ± SD) of amoxicillin given intravenously at a dose of  Table 1. Pharmacokinetic variables (Mean ± SD) of amoxicillin given intravenously at a dose of 
10 mg/kg 10 mg/kg     b.m. b.m.   alone or concomitantly with diclofenac in ewes (n = 10) alone or concomitantly with diclofenac in ewes (n = 10)
Parameters Units
Mean ± SD
Amoxicillin Amoxicillin+  Diclofenac
T1/2a h 0.09 ± 0.01 0.083 ± 0.02 
b /h 0.87 ± 0.12 0.86 ± 0.1 
T1/2b h 0.79 ± 0.11 0.8 ± 0.09 
Vc L/kg 0.06 ± 0.009 0.067 ± 0.007 
Vdss L/kg 0.176 ± 0.04 0.18 ± 0.06 
ClB L/h/kg 0.25 ± 0.02 0.24 ± 0.04 
AUC0-∞ g/h/ml 35.2 ± 6.2 39.48 ± 5.7 
MRT h 0.8 ± 0.15 0.9 ± 0.17 
Table 2. Renal disposition parameters (Mean ± SD) of amoxicillin given intravenously at a dose  Table 2. Renal disposition parameters (Mean ± SD) of amoxicillin given intravenously at a dose 
of 10 mg kg of 10 mg kg-1  -1 b. wt. b. wt.   alone or concomitantly with diclofenac in ewes (n=10)  alone or concomitantly with diclofenac in ewes (n=10) 
Parameters Units
Mean ± SD
Amoxicillin Amoxicillin+  Diclofenac
ClR L/h/kg 0.24  0.05 0.26  0.07 
FC N 1.26 0.3 1.4 0.2
DF % 93.8 ± 9.6 95.3  7.8 
Cl ClR;  R; renal clearance, FC; fractional clearance, DF; cumulative dose fraction recovered up to 12 hours. renal clearance, FC; fractional clearance, DF; cumulative dose fraction recovered up to 12 hours.
The mean values of endogenous creatinine clearance (CLcr) were 0.19 ± 0.06 L/h/
kg, the mean values of fractional clearance (FC) were 1.26 ± 0.3 and 1.4 ± 0.2 and the 
cumulative dose fraction (DF) recovered in the urine within 12 hours post administration 
were 93.8% and 95.3% (Table 2) in ewes treated with amoxicillin alone and amoxicillin 
plus diclofenac, respectively. Amoxicillin was detected in the plasma and urine for 8 
hours for 12 hours post intravenous administration, , in animals treated with amoxicillin 
alone or plus diclofenac respectively.36 Vet. arhiv 84 (1), 31-39, 2014
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Discussion
The clear impact of diclofenac on the plasma levels of amoxicillin as well as certain 
pharmacokinetic variables when both drugs were given concomitantly has been shown 
in rats and humans in previous studies (GROPPO et al., 2004; BERGAMASCHI et al., 2006). 
However, the particular mechanism involved in the interaction of these drugs has not 
been identiﬁ  ed. Thus, this study assessed the impact of diclofenac on renal clearance of 
amoxicillin, following simultaneous administration by intravenous route rather than oral 
route.
In the present study, following the intravenous (i.v.) administration of amoxicillin 
alone or simultaneously with diclofenac, the plasma concentration time curve of 
amoxicillin followed the two compartment open model. This ﬁ  nding is in agreement with 
the previous report by CRAIGMILL et al. (1992) and FERNANDEZ et al. (2007). In contrast, 
other studies employed compartmental pharmacokinetic analysis in sheep (DELIS et al., 
2010) and concluded with a three compartment disposition. 
No signiﬁ  cant differences were reported in pharmacokinetic parameters following 
i.v. administration of amoxicillin alone or simultaneous administration with diclofenac. 
The elimination half-life of amoxicillin reported in this work is close to the value reported 
by CRAIGMILL et al. (1992) and shorter than the values (1.62 h) reported by DELIS et al. 
(2009b) and (1.43 h) by CARCELES et al. (1995) whereas, it was longer than that (0.38 h) 
reported by FERNANDEZ et al. (2007). 
The terminal elimination half-life and MRT for amoxicillin when administered alone 
or plus diclofenac were similar, as conﬁ  rmed by the insigniﬁ  cant difference in the total 
body clearance after both treatments. Total body clearance (ClB) values reported in this 
study for amoxicillin are close to the values reported previously and are located within 
the range of those reported in sheep (0.09-0.61 L/h/kg) by other authors (CRAIGMILL et 
al., 1992; CARCELES et al., 1995; FERNANDEZ et al., 2007). 
The low values of Vdss reported for amoxicillin administered alone or plus diclofenac 
in this study are consistent with its polar nature. Based on the pKa values of amoxicillin 
(2.8, 7.2) , a large fraction of the drugs carry a net negative charge at physiological pH 
and consequently its inability to attain substantial intracellular concentration (AGERSO 
and FRIIS, 1998; BAGGOT, 2001). This ﬁ  nding is in agreement with that reported by 
CRAIGMILL et al. (1992) and DELIS et al. (2009b). 
Diclofenac did not affect the fraction of the dose of amoxicillin recovered unchanged 
in urine and most of the administered dose was recovered unchanged in the urine within 
12 hours of administration of the drug in ewes. Our ﬁ  ndings are consistent with previous 
reports showing that amoxicillin was excreted unchanged by both glomerular ﬁ  ltration 
and active tubular secretion (REYNOLDS, 1996; RIVIERE, 1999; BAGGOT, 2001). The 37 Vet. arhiv 84 (1), 31-39, 2014
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value of renal clearance of amoxicillin administered alone and with diclofenac was close 
to the relevant values for total body clearance and this is consistent with its excretion 
unchanged in urine. The values (1.27 v. 1.4) of fractional clearance (clr/clcr) emphasized 
that renal elimination of amoxicillin in ewes follows the same pattern previously 
mentioned. Additionally, our ﬁ  ndings showed that diclofenac did not signiﬁ  cantly alter 
the renal clearance of amoxicillin. Tubular secretion of beta lactam antibiotics occurs 
mostly via the organic anion transporters (OAT) and the proton-coupled oligopeptide 
transporter (PepT) (HAN et al., 1999; HOSOYAMADA et al., 1999; TERADA et al., 2000). It 
was reported by KHAMDANG et al. (2002) that diclofenac inhibited organic anion uptake. 
Additionally,  LI et al. (2006), has reported that the proton-coupled oligopeptide 
transporter (PepT) is the main tubular transporter for amoxicillin, whereas organic anion 
transporters (OAT) are not involved in the renal uptake of this antibiotic. These ﬁ  ndings 
are consistent with our results regarding the lack of a modulating effect of diclofenac on 
the renal clearance of amoxicillin following concomitant i.v. administration.
 In contrast, an earlier study by BERGAMASCHI et al. (2006) showed a signiﬁ  cant 
reduction in amoxicillin total body clearance of 18%, following concomitant oral 
administration with diclofenac. This difference may be attributed to the signiﬁ  cant 
alteration of diclofenac regarding other oral pharmacokinetic parameters of amoxicillin 
in this study. 
The ﬁ  ndings of the present study show that the hypothesis of the impaired renal 
clearance of amoxicillin by concomitant administration of diclofenac is impractical and 
indicate the lack of pharmacokinetic interaction between amoxicillin given intravenously.
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SAŽETAK
Cilj rada bio je procijeniti učinak diklofenaka na raspodjelu i bubrežni klirens amoksicilina.  Nakon 
jednotjednog razdoblja ispiranja, u 10 ovaca intravenski je bio primijenjen samo amoksicilin (10 mg/kg 
tjelesne mase) ili/i natrijev diklofenak intramuskularno (2,5 mg/kg tjelesne mase) 30 minuta prije primjene 
amoksicilina. Koncentracija amoksicilina u plazmi i mokraći izmjerena je visokotlačnom tekućinskom 
kromatograﬁ  jom na osnovi ﬂ  uorescencije. Primjena diklofenaka s amoksicilinom nije značajno utjecala na 
promjene farmakokinetičkih pokazatelja za amoksicilin ili na njegovo izlučivanje putem bubrega nakon 
intravenske primjene. Srednja vrijednost ± SD poluživota izlučivanja amoksicilina (t1/2) iznosila je kod 
njegove intravenske primjene 0,79 ± 0,11 sati, a kod primjene s diklofenakom  0,8 ± 0,09 sati. Srednje vrijeme 
zadržavanja amoksicilina bilo je 0,8 ± 0,15  sati, a s diklofenakom 0,9 ± 0,17 sati. Ukupni tjelesni klirens za sam 
amoksicilin iznosio je 0,25 ± 0,02 L/h/kg, a u kombinaciji s diklofenakom   0,24 ± 0,04 L/h/kg, dok je srednja 
vrijednost površine ispod krivulje eliminacije samo za amoksicilin bila 35,2 ± 6,2 g/h/mL, a u kombinaciji 
s diklofenakom 9,5 ± 5,7 g/h/mL. Amoksicilin se izlučio nepromijenjen mokraćom s bubrežnim klirensom   
(ClR) od  0,24 ± 0,05 L/h/kg, a primijenjen s diklofenakom od  0,27 ± 0,07 L/h/kg. Može se zaključiti da 
primjena diklofenaka nije imala značajan utjecaj na farmakokinetiku ili izlučivanje amoksicilina primijenjenog 
intravenski u ovaca. 
Ključne riječi: amoksicilin, diklofenak izlučivanje, ovce, farmakokinetika, bubrežni klirens ________________________________________________________________________________________.